HWAIF (Healwell AI) YoY EBITDA Growth: 288.89% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HWAIF Healwell AI Inc HWAIF
51 GF Score
Price $0.56
GF Value $2.31
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Healwell AI YoY EBITDA Growth?

Healwell AI HWAIF +1.18% 51 YoY EBITDA Growth is 288.89% as of Jun. 2026. GuruFocus rates HWAIF with a GF Score™ of 51/100 and a GF Value™ of $2.31 (Possible Value Trap). The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Healwell AI's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 288.89%.

Healwell AI's EBITDA per Share for the three months ended in Jun. 2026 was $0.04.

Healwell AI YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Healwell AI's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healwell AI YoY EBITDA Growth Chart

Healwell AI Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only -1,035.00 -9.63 -77.07 77.41 53.66

Healwell AI Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.73 48.48 90.48 107.89 288.89
HWAIF
51GF Score
Healwell AI Inc HWAIF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healwell AI YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Healwell AI's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.038--0.082)/ | -0.082 |
=53.66 %

Healwell AI's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.035-0.009)/ | 0.009 |
=288.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 288.89% mean?
Healwell AI (HWAIF) has a YoY EBITDA Growth of 288.89% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Healwell AI and its competitors.
Is Healwell AI's YoY EBITDA Growth too high?
Healwell AI's current YoY EBITDA Growth is 288.89%. Overall, Healwell AI has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healwell AI's YoY EBITDA Growth compare to HCA and THC?
Healwell AI's YoY EBITDA Growth of 288.89% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Healwell AI and its competitors. Healwell AI's current YoY EBITDA Growth is 288.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healwell AI stock overvalued right now?
Based on GuruFocus' analysis, Healwell AI (HWAIF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.31, compared to a current price of $0.56 — trading 75.6% below its estimated fair value. The current YoY EBITDA Growth is 288.89%. Healwell AI's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Healwell AI (HWAIF), the current YoY EBITDA Growth is 288.89% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healwell AI (HWAIF) Overvalued in 2026?

Based on GuruFocus' analysis, Healwell AI stock appears to be undervalued. The current stock price of $0.56 is trading 75.6% below its estimated GF Value™ of $2.31. GuruFocus considers Healwell AI to be Possible Value Trap.

Key valuation signals for HWAIF:

  • YoY EBITDA Growth: 288.89%
  • GF Value™: $2.31 vs. price of $0.56 (75.6% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the HWAIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healwell AI Business Description

Other Exchanges 6H90:GermanyAIDX:Canada
Address 460 College Street, Unit 301, Toronto, ON, CAN, M6G 1A1
Healwell AI Inc is a Canadian healthcare technology company. It operates in two reportable segments: Al and Data Sciences, and Healthcare Software. The majority of Healwell's revenue is generated from the Healthcare Software segment, whose core software suite consists of Electronic Health Records (EHR), Digital Front Door (DFD), and Digital Care Records (DCR). These products consolidate diverse data sources, helping physicians get a comprehensive view of individual patient health. The AI and Data Sciences division offers AI technologies and algorithms that screen clinical information and patient records, and aid in identifying patients at high risk for specific conditions. Geographically, the company generates maximum revenue from Australia and New Zealand, and the rest from Canada.
51GF Score

Get the complete analysis for HWAIF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$2.31
GF Value